Modelling hematopoiesis in health and disease

Mathematical and Computer Modelling

Volumn 53, Issue 7-8, 2011, Pages 1546-1557

  Peixoto, Diogo ^a   Dingli, David ^b   Pacheco, Jorge M ^a,c  

^a Universidade de Lisboa   (Portugal)

^b Mayo Clinic College of Medicine   (United States)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

Cancer modelling; Hematopoiesis; Mathematical modelling; Somatic evolution of cancer; Stochastic processes

Indexed keywords

CANCER MODELLING; HEMATOPOIESIS; MATHEMATICAL MODELLING; SOMATIC EVOLUTION OF CANCER; STOCHASTIC PROCESS;

CELL PROLIFERATION; DISEASES; MAMMALS; RANDOM PROCESSES; STEM CELLS; STOCHASTIC MODELS; STOCHASTIC SYSTEMS;

BLOOD;

EID: 79951581181     PISSN: 08957177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcm.2010.04.013     Document Type: Article

References (77)

1. Vaziri H., et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 1994, 91(21):9857-9860.
2. Holyoake T.L., et al. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia 2002, 16(4):549-558.
3. Tefferi A. Polycythemia vera: a comprehensive review and clinical recommendations. Mayo Clin. Proc. 2003, 78(2):174-194.
4. Abkowitz J.L., Catlin S.N., Guttorp P. Evidence that hematopoiesis may be a stochastic process in vivo. Nat. Med. 1996, 2(2):190-197.
5. Gordon M.Y., Blackett N.M. Routes to repopulation-a unification of the stochastic model and separation of stem-cell subpopulations. Leukemia 1994, 8(6):1068-1072. discussion 1072-3.
6. McCulloch E.A., Till J.E. Proliferation of hemopoietic colony-forming cells transplanted into irradiated mice. Radiat. Res. 1964, 22:383-397.
7. McCulloch E.A., Till J.E. Perspectives on the properties of stem cells. Nat. Med. 2005, 11(10):1026-1028.
8. Appelbaum F.R. Hematopoietic-cell transplantation at 50. N. Engl. J. Med. 2007, 357(15):1472-1475.
9. Mackey M.C. Cell kinetic status of haematopoietic stem cells. Cell Prolif. 2001, 34(2):71-83.
10. Haurie C., Dale D.C., Mackey M.C. Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models. Blood 1998, 92(8):2629-2640.
11. Haurie C., Dale D.C., Mackey M.C. Occurrence of periodic oscillations in the differential blood counts of congenital, idiopathic, and cyclical neutropenic patients before and during treatment with G-CSF. Exp. Hematol. 1999, 27(3):401-409.
12. Haurie C., et al. Modeling complex neutrophil dynamics in the grey collie. J. Theoret. Biol. 2000, 204(4):505-519.
13. Haurie C., et al. Hematopoietic dynamics in grey collies. Exp. Hematol. 1999, 27(7):1139-1148.
14. Colijn C., Mackey M.C. A mathematical model of hematopoiesis: II. Cyclical neutropenia. J. Theoret. Biol. 2005, 237(2):133-146.
15. Colijn C., Mackey M.C. A mathematical model of hematopoiesis-I. Periodic chronic myelogenous leukemia. J. Theoret. Biol. 2005, 237(2):117-132.
16. Shochat E., Stemmer S.M., Segel L. Human haematopoiesis in steady state and following intense perturbations. Bull. Math. Biol. 2002, 64(5):861-886.
17. Schmitz S., et al. Model analysis of the contrasting effects of GM-CSF and G-CSF treatment on peripheral blood neutrophils observed in three patients with childhood-onset cyclic neutropenia. Br. J. Heamatol. 1996, 95(4):616-625.
18. Schmitz S., et al. Synchrony of bone marrow proliferation and maturation as the origin of cyclic haemopoiesis. Cell Tissue Kinet. 1990, 23(5):425-442.
19. Wichmann H.E., et al. Mathematische modelle in der haematologie. Klin. Wochenschr. 1983, 61:935-940.
20. Foley C., Bernard S., Mackey M.C. Cost-effective G-CSF therapy strategies for cyclical neutropenia: mathematical modelling based hypotheses. J. Theoret. Biol. 2006, 238(4):754-763.
21. Dingli D., Traulsen A., Pacheco J.M. Compartmental architecture and dynamics of hematopoiesis. PLoS One 2007, 2:e345.
22. Quesenberry P.J., et al. Stromal regulation of hemopoiesis and the role of subliminal growth factor production. Leukemia 1993, 7(Suppl. 2):S3-S4.
23. Buescher E.S., Alling D.W., Gallin J.I. Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. J. Clin. Invest. 1985, 76(4):1581-1584.
24. Nash R., Storb R., Neiman P. Polyclonal reconstitution of human marrow after allogeneic bone marrow transplantation. Blood 1988, 72(6):2031-2037.
25. Abkowitz J.L., et al. Behavior of hematopoietic stem cells in a large animal. Proc. Natl. Acad. Sci. USA 1995, 92(6):2031-2035.
26. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978, 4(1-2):7-25.
27. Lopes J.V., Pacheco J.M., Dingli D. Acquired hematopoietic stem cell disorders and mammalian size. Blood 2007, 110:4137-4139.
28. Purnick P.E., Weiss R. The second wave of synthetic biology: from modules to systems. Nat. Rev. Mol. Cell Biol. 2009, 10(6):410-422.
29. Teuscher C., et al. Bio-inspired computing tissues: towards machines that evolve, grow, and learn. Biosystems 2003, 68:235-244.
30. Zhang Y., Ruder W.C., LeDuc P.R. Artificial cells: building bioinspired systems using small-scale biology. Trends Biotechnol. 2008, 26(1):14-20.
31. McKenzie J.L., et al. Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment. Nat. Immunol. 2006, 7(11):1225-1233.
32. Abkowitz J.L., et al. Evidence for the maintenance of hematopoiesis in a large animal by the sequential activation of stem-cell clones. Proc. Natl. Acad. Sci. USA 1990, 87(22):9062-9066.
33. Dingli D., Traulsen A., Michor F. (A)symmetric stem cell replication and cancer. PLoS Comput. Biol. 2007, 3(3):e53.
34. Dingli D., Traulsen A., Pacheco J.M. Stochastic dynamics of hematopoietic tumor stem cells. Cell Cycle 2007, 6(4):441-446.
35. Traulsen A., Pacheco J.M., Dingli D. On the origin of multiple mutant clones in paroxysmal nocturnal hemoglobinuria. Stem Cells 2007, 25(12):3081-3084.
36. Huxley J.S. Problems of Relative Growth 1932, Dial Press, New York, USA.
37. West G.B., Brown J.H., Enquist B.J. The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 1999, 284(5420):1677-1679.
38. West G.B., Brown J.H. The origin of allometric scaling laws in biology from genomes to ecosystems: towards a quantitative unifying theory of biological structure and organization. J. Exp. Biol. 2005, 208(Pt 9):1575-1592.
39. Banavar J.R., Maritan A., Rinaldo A. Size and form in efficient transportation networks. Nature 1999, 399(6732):130-132.
40. Dingli D., Pacheco J.M. Allometric scaling of the active hematopoietic stem cell pool across mammals. PLoS One 2006, 1:e2.
41. Spangrude G.J., et al. Mouse hematopoietic stem cells. Blood 1991, 78(6):1395-1402.
42. Lemischka I.R., Raulet D.H., Mulligan R.C. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 1986, 45(6):917-927.
43. Abkowitz J.L., et al. Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood 2002, 100(7):2665-2667.
44. McCarthy K.F. Population size and radiosensitivity of murine hematopoietic endogenous long-term repopulating cells. Blood 1997, 89(3):834-841.
45. McCarthy K.F. Marrow frequency of rat long-term repopulating cells: evidence that marrow hematopoietic stem cell concentration may be inversely proportional to species body weight. Blood 2003, 101(9):3431-3435.
46. Gordon M.Y., Lewis J.L., Marley S.B. Of mice and men ... and elephants. Blood 2002, 100(13):4679-4680.
47. Dingli D., Pacheco J.M. Ontogenic growth of the haemopoietic stem cell pool in humans. Proc. Biol. Sci. 2007, 274(1624):2497-2501.
48. Goldman J.M. Chronic myeloid leukemia-still a few questions. Exp. Hematol. 2004, 32(1):2-10.
49. Luzzatto L., Bessler M., Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise?. Cell 1997, 88(1):1-4.
50. Massey G.V., et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down Syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood 2006, 107(12):4606-4613.
51. Tricot G., Mecucci C., Van den Berghe H. Evolution of the myelodysplastic syndromes. Br. J. Heamatol. 1986, 63(4):609-614.
52. Zipursky A. Transient leukaemia-a benign form of leukaemia in newborn infants with trisomy 21. Br. J. Heamatol. 2003, 120(6):930-938.
53. Bose S., et al. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 1998, 92(9):3362-3367.
54. Dingli D., Luzzatto L., Pacheco J.M. Neutral evolution in paroxysmal nocturnal hemoglobinuria. Proc. Natl. Acad. Sci. USA 2008, 105(47):18496-18500.
55. Marley S.B., Lewis J.L., Gordon M.Y. Progenitor cells divide symmetrically to generate new colony-forming cells and clonal heterogeneity. Br. J. Heamatol. 2003, 121(4):643-648.
56. Donohue D.M., et al. Quantitative measurement of the erythrocytic and granulocytic cells of the marrow and blood. J. Clin. Invest. 1958, 37(11):1571-1576.
57. Finch C.A., Harker L.A., Cook J.D. Kinetics of the formed elements of human blood. Blood 1977, 50(4):699-707.
58. Rufer N., et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J. Exp. Med. 1999, 190(2):157-167.
59. Cronkite E.P., Fliedner T.M. Granulocytopoiesis. N. Engl. J. Med. 1964, 270:1347-1352.
60. Araten D.J., et al. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc. Natl. Acad. Sci. USA 1999, 96(9):5209-5214.
61. Parker C., et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005, 106(12):3699-3709.
62. Araten D.J., Luzzatto L. The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood 2006, 108(2):734-736.
63. Dingli D., Pacheco J.M., Traulsen A. Multiple mutant clones in blood rarely coexist. Phys. Rev. E 2008, 77:021915.
64. Dingli D., et al. Progenitor cell self-renewal and cyclic neutropenia. Cell Prolif. 2009, 42(3):330-338.
65. Dingli D., Traulsen A., Pacheco J.M. Chronic myeloid leukemia: origin, development, response to therapy and relapse. Clin. Leuk. 2008, 2(2):133-139.
66. Dingli D., Traulsen A., Pacheco J.M. Dynamics of haemopoiesis across mammals. Proc. Biol. Sci. 2008, 275(1649):2389-2392.
67. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 1961, 25:585-621.
68. Shepherd B.E., et al. Hematopoietic stem cell behavior in non-human primates. Blood 2007, 110(6):1806-1813.
69. Pacheco J.M., et al. Cyclic neutropenia in mammals. Am. J. Hematol. 2008, 83(12):920-921.
70. Michor F., et al. Dynamics of chronic myeloid leukaemia. Nature 2005, 435(7046):1267-1270.
71. Roeder I., et al. Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications. Nat. Med. 2006, 12(10):1181-1184.
72. Brummendorf T.H., et al. Longitudinal studies of telomere length in feline blood cells: implications for hematopoietic stem cell turnover in vivo. Exp. Hematol. 2002, 30(10):1147-1152.
73. Marley S.B., et al. The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia. Exp. Hematol. 2000, 28(5):551-557.
74. Horwitz M.S., et al. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 2007, 109(5):1817-1824.
75. Grenda D.S., et al. Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis. Blood 2002, 100(9):3221-3228.
76. Hillmen P., Hows J.M., Luzzatto L. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria. Br. J. Heamatol. 1992, 80(3):399-405.
77. Hillmen P., et al. Natural history of paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 1995, 333(19):1253-1258.